Over the course of civilization, humans have increasingly expanded their freedom to live a better life. In comparison with the primitive society, our modern society has many more choices of life-supporting resources, such as year-round food supply, permanent shelters, diverse energy sources, and effective preventive and curing medicine. However, our society is currently still heavily relying on the resources provided by Mother Nature, which cannot meet the future global needs in terms of both quantity and quality under the pressure of population growth, natural resource reduction, and environmental deterioration. For example, the food sources originating from plants, animals, or microbes do not have the nutrition balance for optimal human health [1–3]. Climate change and environmental deterioration threaten the food security [4–6]. Increasingly, infectious diseases (e.g., HIV/AIDS), genetic diseases (e.g., cancer), and improper lifestyle-related disorders (e.g., obesity) become more prevalent and remain challenging to be prevented, controlled, and cured. Conventional medical technologies and modern medicine development are also meeting the ceiling. Antibiotic resistance is threatening the health of humans, animals, and environment . As the human lifespan continues to increase, aging-related diseases, disorders, and poor life quality are becoming global challenges . Plants, animals, and microbes in nature have evolved as part of our Earth ecosystem, not for benefiting humans. Even though humans have put forth tremendous efforts to domesticate plants, animals, and microbes based on random/induced mutations, hybridization, and limited genetic modifications via biological engineering, the improved food and industrial crop plants, animals, and microbial strains are still far from optimized for meeting the human needs. In other words, natural evolution and domestication in plants, animals, and microbes are tinkering processes and therefore cannot meet the ever-exploding population on the one hand and the unending appetite for living better quality life on the other. One promising strategy for solving these global challenges is to employ revolutionary biosystems design (also called biodesign), which is defined as predictable modification of existing organisms or creation of new organisms using rational engineering or automated design based on the theory and principles of biosystems design.
Biodesign in living organisms deals with the structure of the particular organism and the interactions between the biomolecules encoded in their genomes. In the broadest sense, biodesign is concerned with the nature and properties of the information required to create biological behavior at the ecological, organism, cellular, organelle, and molecular levels and how biological systems interface with the environment and devices. The explosion of omics data (i.e., genomics, transcriptomics, proteomics, metabolomics, and phenomics), the rapid advance in computational modeling and machine learning, the reduced cost of omics data generation and analysis and DNA/RNA and protein synthesis, and the disruptive genome editing technology based on CRISPR- (Clustered Regularly Interspaced Short Palindromic Repeats-) Cas (CRISPR-associated) systems have accelerated the evolution of biodesign as a next-generation discipline of biology, as best reflected by a rapid increase in the number of publications related to biodesign since a decade ago (Figure 1). As a consequence of the new paradigm shift of biology by integrating genome reading with genome editing and rewriting, biodesign promises to solve three critical challenges: (1) integrating large-scale omics data with computational modeling to gain a comprehensive and deep understanding of the structure and function of complex networks and pathways in all types of organisms and to systematically link genes (causes) to traits (effects or phenotypes); (2) improving the existing commodity organisms (e.g., agricultural and industrial crops, livestock, and industrial microbes) and most importantly human health through molecular design of new pharmaceuticals, postembryotic gene editing and therapy, intelligent genetic circuits, and pathway/tissue engineering; and (3) creating novel traits or function through large-scale DNA synthesis and genome writing and rewriting within the framework of social responsibility and professional ethics.
With unlimited potential in fundamental research, broad practical applications, and ever-increasing amount of R&D funding support from government agencies, industries, and government/industry consortia around the world, biodesign is growing into a new interdisciplinary field that integrates a wide range of research areas, including molecular biology, genetics, biochemistry, genomics, chemical engineering, computational biology, bioinformatics, synthetic biology, systems biology, physiology, ecology, breeding, medical science, animal science, microbiology, crop science, horticulture, and forestry. To embrace the promise of this fast-growing research discipline, this journal was launched to advance both fundamental and applied research, foster multidisciplinary collaboration, and promote dissemination of scientific information and knowledge in the field of biosystems design. This new journal will emphasize the rational or automated design of engineered organisms to address global challenges in health, agriculture, bioenergy, and the environment. It will promote research, with the increasing sophistication and greater social responsibility, on the predictable conduct of (1) engineered biological parts in an exogenous genomic context, (2) engineered part assemblies (gene circuits, pathways, and macromolecular assemblies) in an exogenous compartment context, (3) engineered assemblies in an exogenous cell, (4) engineered cells in an exogenous tissue, and (5) engineered tissues in an exogenous organism.
This journal will feature a framework that integrates the following three dimensions: (1) scientific dimension: biodesign theory, principles, methodology, tools, and applications; (2) organismal dimension: animal, human, microbial, plant, and de novo organism biodesign; and (3) social responsibility dimension: biodesign security and ethics (Figure 2). While biosystems design research can make a huge positive impact on a wide range of disciplines, it should be regulated by an “on/off” switch based on the aspects of biodesign security and ethics to avoid any negative consequences, such as the unethical use of gene editing in human germ cells [9, 10].
As a vigorously peer-reviewed, open-access online-only journal, it is dedicated to rapid, efficient, and free worldwide dissemination of scientific discoveries, technological advancements, and social responsibilities in the format of research articles, reviews, editorials, and perspectives. We are honored and humbled to serve the biodesign community as the founding editors-in-chief and executive editor and are extremely grateful to highly reputable experts to serve as associate editors. This journal welcomes high-quality manuscripts from researchers around the world. We hope that this journal will grow fast and healthy to become a leading journal in the field of biodesign through collective efforts of the editorial board, authors, reviewers, and readers.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
The writing of this manuscript was supported by the Center for Bioenergy Innovation (CBI), a U.S. Department of Energy (DOE) Bioenergy Research Center supported by the Office of Science, Office of Biological and Environmental Research (OBER). This manuscript has been authored by UT-Battelle, LLC under Contract No. DE-AC05-00OR22725 with the U.S. Department of Energy. Oak Ridge National Laboratory is managed by UT-Battelle, LLC for the U.S. Department of Energy under Contract Number DE-AC05-00OR22725. L.S.Q. is supported by the Department of Defense and Li Ka Shing Foundation for the work. A.J. is supported by BBSRC grant EVO-ENGINE BB/P020615/1 and EPSRC-BBSRC (no. BB/M017982/1, WISB Center). Research in Cheng’s Lab is supported by the Tennessee Agricultural Experiment Station Hatch Project TEN00491. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a nonexclusive, paid-up, irrevocable, worldwide license to publish or reproduce the published form of this manuscript, or allow others to do so, for United States Government purposes. The Department of Energy will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (https://energy.gov/downloads/doe-public-access-plan).
Lei S. Qi
Zong-Ming (Max) Cheng
- J. Fudge, N. Mangel, W. Gruissem, H. Vanderschuren, and T. B. Fitzpatrick, “Rationalising vitamin B6 biofortification in crop plants,” Current Opinion in Biotechnology, vol. 44, pp. 130–137, 2017.
- A. D. Jones and G. Ejeta, “A new global agenda for nutrition and health: the importance of agriculture and food systems,” Bulletin of the World Health Organization, vol. 94, no. 3, pp. 228-229, 2016.
- D. C. Sands, C. E. Morris, E. A. Dratz, and A. L. Pilgeram, “Elevating optimal human nutrition to a central goal of plant breeding and production of plant-based foods,” Plant Science, vol. 177, no. 5, pp. 377–389, 2009.
- B. M. Campbell, S. J. Vermeulen, P. K. Aggarwal et al., “Reducing risks to food security from climate change,” Global Food Security, vol. 11, pp. 34–43, 2016.
- M. C. Nelson, S. E. Ingram, A. J. Dugmore et al., “Climate challenges, vulnerabilities, and food security,” Proceedings of the National Academy of Sciences, vol. 113, no. 2, pp. 298–303, 2016.
- X. Qi, Y. Fu, R. Y. Wang, C. N. Ng, H. Dang, and Y. He, “Improving the sustainability of agricultural land use: an integrated framework for the conflict between food security and environmental deterioration,” Applied Geography, vol. 90, pp. 214–223, 2018.
- B. Aslam, W. Wang, M. I. Arshad et al., “Antibiotic resistance: a rundown of a global crisis,” Infection and Drug Resistance, vol. 11, pp. 1645–1658, 2018.
- L. Partridge, J. Deelen, and P. E. Slagboom, “Facing up to the global challenges of ageing,” Nature, vol. 561, no. 7721, pp. 45–56, 2018.
- D. Cyranoski, “The CRISPR-baby scandal: what’s next for human gene-editing,” Nature, vol. 566, no. 7745, pp. 440–442, 2019.
- E. S. Lander, F. Baylis, F. Zhang et al., “Adopt a moratorium on heritable genome editing,” Nature, vol. 567, no. 7747, pp. 165–168, 2019.